Reprogramming of glucose and lipid metabolism is one of the key properties intrinsic in aggressive cancer cells, due to which they acquire advantages for their survival, growth and avoidance of the antitumor immune response. The aim of this review is to search for selective oncotargets underlying the reprogramming of metabolic oncopathways, as well as to identify their most effective inhibitors. The main inhibitors capable of effectively suppressing cancer aerobic glycolysis and triggering cancer cell death were analyzed to test this assumption. Attention was also focused on the ability of cancer cells to collectively suppress the local immune response, in particular, due to the synthesis and secretion of cancer lipid granules. A metabolic model explaining the origin of this effect in the cancer microenvironment was also developed.
Selective Metabolic Targets and Their Inhibitors in Oncological Diseases: Potential and Prospects
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 142290, Russian Federation
Article History
ReceivedSeptember 21, 2026
AcceptedNovember 6, 2026
Available OnlineNovember 9, 2026